667 related articles for article (PubMed ID: 18494826)
21. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
[TBL] [Abstract][Full Text] [Related]
22. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
23. Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.
Perry BN; Cohen C; Govindarajan B; Cotsonis G; Arbiser JL
Arch Dermatol; 2006 Aug; 142(8):1031-4. PubMed ID: 16924053
[TBL] [Abstract][Full Text] [Related]
24. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
25. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study.
Marghoob AA; Schoenbach SP; Kopf AW; Orlow SJ; Nossa R; Bart RS
Arch Dermatol; 1996 Feb; 132(2):170-5. PubMed ID: 8629825
[TBL] [Abstract][Full Text] [Related]
26. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
27. [Congenital nevus cell nevi as precursors of melanomas of the skin].
Schnyder UW; Schneider BV; Maie O; Groh V; Sigg C
Monatsschr Kinderheilkd; 1987 May; 135(5):259-64. PubMed ID: 3614220
[TBL] [Abstract][Full Text] [Related]
28. [Congenital melanocytic nevi--a multifaceted problem].
Hamm H
MMW Fortschr Med; 2007 Feb; 149(6):33-5. PubMed ID: 17619400
[TBL] [Abstract][Full Text] [Related]
29. Comparison of classification systems for congenital melanocytic nevi.
Turkmen A; Isik D; Bekerecioglu M
Dermatol Surg; 2010 Oct; 36(10):1554-62. PubMed ID: 20584038
[TBL] [Abstract][Full Text] [Related]
30. Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma.
de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
Ann Diagn Pathol; 2013 Feb; 17(1):32-6. PubMed ID: 22652151
[TBL] [Abstract][Full Text] [Related]
31. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
32. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
33. Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
Batinac T; Hadzisejdić I; Brumini G; Ruzić A; Vojniković B; Zamolo G
Coll Antropol; 2007 Jan; 31 Suppl 1():17-22. PubMed ID: 17469743
[TBL] [Abstract][Full Text] [Related]
34. The relationship between melanocytic nevi and malignant melanoma.
Friedman RJ; Rigel DS; Heilman ER
Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
[TBL] [Abstract][Full Text] [Related]
35. Melanocytic nevi and malignant melanoma.
Metcalf JS; Maize JC
Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
[TBL] [Abstract][Full Text] [Related]
36. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
[TBL] [Abstract][Full Text] [Related]
37. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
[TBL] [Abstract][Full Text] [Related]
38. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
Poyraz A; Akyürek N; Gönül II; Erdem O
J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
[TBL] [Abstract][Full Text] [Related]
39. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
40. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
